Pharmaceutical Executive Magazine
http://pharmexec.findpharma.com/pharmexec
The publisher of Pharmaceutical Executive brings visitors PharmExec.com, which serves up a daily dose
of news and features from the world of pharma business and marketing.2008-07-05T00:02:59ZNew Act to Protect Patients Could Cripple Preemption
http://pharmexec.findpharma.com/pharmexec/Regulatory/New-Act-to-Protect-Patients-Could-Cripple-Preempti/ArticleStandard/Article/detail/527134?ref=25
Congressman Waxman and Pallone introduced a new legislation that could reverse the recent Riegel v.
Medtronic decision. How will the ramifications of this act effect the upcoming pharma preemption
case?2008-07-02T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/272008/527134nullHTMLNew Educational Program to Boost PR Compliance
http://pharmexec.findpharma.com/pharmexec/Marketing/New-Educational-Program-to-Boost-PR-Compliance/ArticleStandard/Article/detail/527136?ref=25
With the launch of the Center for Communication Compliance, pharma companies and PR firms have a
one-stop resource to educate themselves about marketing regulations in an effort to reduce accidental
non-compliance.2008-07-02T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/272008/527136nullHTMLPharma CEOs Expound on Industry Change
http://pharmexec.findpharma.com/pharmexec/News/Pharma-CEOs-Expound-on-Industry-Change/ArticleStandard/Article/detail/527131?ref=25
A new global CEO study examines what near- and long-term changes pharma leaders expect to face and in
what areas they are planning to focus their attention. Key focus areas: global business design and new
markets.2008-07-02T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/272008/527131nullHTMLNew Electrostatic-Based DNA Microarray Technique Could Revolutionize Medical Diagnostics
http://pharmexec.findpharma.com/pharmexec/Discovery+NewsWire/New-Electrostatic-Based-DNA-Microarray-Technique-C/ArticleNewsFeed/Article/detail/526888?ref=25
2008-06-30T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlenewsfeed/pharmexec/272008/526888nullXMLZinc Finger Proteins Put Personalized HIV Therapy Within Reach; Penn Researchers Modify T-Cell Receptor Gene
to Develop New Type of AIDS Treatment
http://pharmexec.findpharma.com/pharmexec/Discovery+NewsWire/Zinc-Finger-Proteins-Put-Personalized-HIV-Therapy-/ArticleNewsFeed/Article/detail/526943?ref=25
2008-06-30T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlenewsfeed/pharmexec/272008/526943nullXMLState and Territorial Health Officials Take Critical Steps to Protect Vulnerable Populations; Association
Releases Pandemic Preparedness Guidance
http://pharmexec.findpharma.com/pharmexec/Discovery+NewsWire/State-and-Territorial-Health-Officials-Take-Critic/ArticleNewsFeed/Article/detail/526887?ref=25
2008-06-30T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlenewsfeed/pharmexec/272008/526887nullXMLDrug Treatment for Marfan Syndrome Looks Promising, Johns Hopkins Researchers Say
http://pharmexec.findpharma.com/pharmexec/Discovery+NewsWire/Drug-Treatment-for-Marfan-Syndrome-Looks-Promising/ArticleNewsFeed/Article/detail/526173?ref=25
2008-06-25T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlenewsfeed/pharmexec/262008/526173nullXMLMicroRNAs Provide New Insight in Study of Autism, UC Santa Barbara Scientist Reports
http://pharmexec.findpharma.com/pharmexec/Discovery+NewsWire/MicroRNAs-Provide-New-Insight-in-Study-of-Autism-U/ArticleNewsFeed/Article/detail/526174?ref=25
2008-06-25T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlenewsfeed/pharmexec/262008/526174nullXMLFDAAA Spelled Out at DIA
http://pharmexec.findpharma.com/pharmexec/Online+Only/FDAAA-Spelled-Out-at-DIA/ArticleStandard/Article/detail/525750?ref=25
Feds walk the industry through the implementation of new drug safety legislation. Not surprisingly,
money and staffing are the biggest issues.2008-06-25T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/262008/525750nullHTMLNew Plant Means New Jobs
http://pharmexec.findpharma.com/pharmexec/Online+Only/New-Plant-Means-New-Jobs/ArticleStandard/Article/detail/525746?ref=25
Merck bolsters vaccine making division with the addition of 400 new employees to fill its new
manufacturing plant.2008-06-25T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/262008/525746nullHTMLOur Genome Changes Over Lifetime, Johns Hopkins Experts Say; May Explain Many 'Late-Onset' Diseases
http://pharmexec.findpharma.com/pharmexec/Discovery+NewsWire/Our-Genome-Changes-Over-Lifetime-Johns-Hopkins-Exp/ArticleNewsFeed/Article/detail/525898?ref=25
2008-06-24T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlenewsfeed/pharmexec/262008/525898nullXMLDana-Farber Cancer Institute Launches National Cancer Education Initiative; Sixty-Six Percent of Oncologists
Cite New Developments as Reasons to Seek Continuing Medical Education
http://pharmexec.findpharma.com/pharmexec/Discovery+NewsWire/Dana-Farber-Cancer-Institute-Launches-National-Can/ArticleNewsFeed/Article/detail/525840?ref=25
2008-06-24T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlenewsfeed/pharmexec/262008/525840nullXMLACE BioSciences and PATH Announce New Collaboration to Develop a Vaccine Against Diarrheal Disease;
Partnership Will Accelerate Development of the ACE527 Vaccine Against Enterotoxigenic Escherichia Coli
(ETEC)
http://pharmexec.findpharma.com/pharmexec/Discovery+NewsWire/ACE-BioSciences-and-PATH-Announce-New-Collaboratio/ArticleNewsFeed/Article/detail/525034?ref=25
2008-06-19T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlenewsfeed/pharmexec/252008/525034nullXMLStudy: Breast Cancer Patients With Greater Need Seek More Information Online
http://pharmexec.findpharma.com/pharmexec/Discovery+NewsWire/Study-Breast-Cancer-Patients-With-Greater-Need-See/ArticleNewsFeed/Article/detail/524896?ref=25
2008-06-18T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlenewsfeed/pharmexec/252008/524896nullXMLAMA Tables Plan to Ban CME Funding
http://pharmexec.findpharma.com/pharmexec/Marketing/AMA-Tables-Plan-to-Ban-CME-Funding/ArticleStandard/Article/detail/524474?ref=25
The American Medical Association's proposal to keep pharma from funding CME programs was put on hold
for further review. But don?t expect the plan to disappear for good.2008-06-18T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524474nullHTMLPharma to Sit on DTC Ads
http://pharmexec.findpharma.com/pharmexec/Marketing/Pharma-to-Sit-on-DTC-Ads/ArticleStandard/Article/detail/524472?ref=25
On Monday, a handful of Big Pharma companies told Congress that they would put a six-month moratorium
on drug ads for recently approved medication. Pfizer, Merck, Schering-Plough, and Johnson & Johnson
also agreed to closely follow the American Medical Association's guidelines when using actors playing physicians in
advertisements.2008-06-18T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524472nullHTMLFDA Takes War Against Fake Meds Online
http://pharmexec.findpharma.com/pharmexec/Online+Only/FDA-Takes-War-Against-Fake-Meds-Online/ArticleStandard/Article/detail/524473?ref=25
FDA announced on Tuesday that it will go on the offensive against online pharmaceutical dealers
selling fraudulent cancer products. The agency told reporters that it has sent 25 warning letters to companies
actively marketing and selling drugs that have not been approved for treatment. A spokesperson said that the drugs
in question could interfere with medication a patient is already taking, or could be used to forgo medically
accepted treatment plans.2008-06-18T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524473nullHTMLStay or Go? Hopkins Researchers Discover One Controller of Cell Movement; May Shed Light on Cancer
Spread
http://pharmexec.findpharma.com/pharmexec/Discovery+NewsWire/Stay-or-Go-Hopkins-Researchers-Discover-One-Contro/ArticleNewsFeed/Article/detail/524830?ref=25
2008-06-18T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlenewsfeed/pharmexec/252008/524830nullXMLEffective Treatment for Sickle Cell Underused by Doctors
http://pharmexec.findpharma.com/pharmexec/Discovery+NewsWire/Effective-Treatment-for-Sickle-Cell-Underused-by-D/ArticleNewsFeed/Article/detail/524523?ref=25
2008-06-17T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlenewsfeed/pharmexec/252008/524523nullXMLPenn Researchers Find Key Developmental Pathway Activates Lung Stem Cells; Pathway Could Hold Promise for
Lung Tissue Repair
http://pharmexec.findpharma.com/pharmexec/Discovery+NewsWire/Penn-Researchers-Find-Key-Developmental-Pathway-Ac/ArticleNewsFeed/Article/detail/524525?ref=25
2008-06-17T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlenewsfeed/pharmexec/252008/524525nullXMLLou Gehrig's Disease Protein Found Throughout Brain, Suggesting Effects Beyond Motor Neurons
http://pharmexec.findpharma.com/pharmexec/Discovery+NewsWire/Lou-Gehrigs-Disease-Protein-Found-Throughout-Brain/ArticleNewsFeed/Article/detail/524303?ref=25
2008-06-16T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlenewsfeed/pharmexec/252008/524303nullXMLUniversity of Virginia Engineers Develop Novel Device to Help Treat Ear Infections
http://pharmexec.findpharma.com/pharmexec/Discovery+NewsWire/University-of-Virginia-Engineers-Develop-Novel-Dev/ArticleNewsFeed/Article/detail/524302?ref=25
2008-06-16T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlenewsfeed/pharmexec/252008/524302nullXMLNew Index Explains Why Some Drugs Work Better Than Others Against HIV
http://pharmexec.findpharma.com/pharmexec/Discovery+NewsWire/New-Index-Explains-Why-Some-Drugs-Work-Better-Than/ArticleNewsFeed/Article/detail/524301?ref=25
2008-06-15T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlenewsfeed/pharmexec/252008/524301nullXMLRegranex Foot Gel Gets Stiffer Warnings
http://pharmexec.findpharma.com/pharmexec/Regulatory/Regranex-Foot-Gel-Gets-Stiffer-Warnings/ArticleStandard/Article/detail/522920?ref=25
J&J topical formulation receives black box warning after a study revealed that the drug
increases the mortality rate from cancer in a subset of patients.2008-06-11T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242008/522920nullHTMLSanofi-Aventis to Trim Sales Force
http://pharmexec.findpharma.com/pharmexec/Strategy/Sanofi-Aventis-to-Trim-Sales-Force/ArticleStandard/Article/detail/522922?ref=25
French drugmaker to cut 800 jobs, joining the long list of companies restructuring to make ends
meet.2008-06-11T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242008/522922nullHTMLRoche Touts Positive Data for Investigational Diabetes Drug
http://pharmexec.findpharma.com/pharmexec/R%26D/Roche-Touts-Positive-Data-for-Investigational-Diab/ArticleStandard/Article/detail/522918?ref=25
Swiss pharma giant Roche was abuzz at ADA, announcing that its new diabetes treatment is set for Phase
III trials and commenting on future plans for failed CETP inhibitor dalcetrapib.2008-06-11T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242008/522918nullHTML'HiCy' Drug Regimen Reverses MS Symptoms in Selected Patients; New Approach to Immunosuppressant Treatment
Tested in Nine Individuals Shows Promise
http://pharmexec.findpharma.com/pharmexec/Discovery+NewsWire/HiCy-Drug-Regimen-Reverses-MS-Symptoms-in-Selected/ArticleNewsFeed/Article/detail/522989?ref=25
2008-06-10T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlenewsfeed/pharmexec/242008/522989nullXMLBrain Stem Cells Can Be Awakened, Say Schepens Scientists; Study Findings Promise to Help in Treatment of
Brain Diseases
http://pharmexec.findpharma.com/pharmexec/Discovery+NewsWire/Brain-Stem-Cells-Can-Be-Awakened-Say-Schepens-Scie/ArticleNewsFeed/Article/detail/522273?ref=25
2008-06-06T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlenewsfeed/pharmexec/232008/522273nullXMLNetwork of Cancer Public Affairs and Marketing Professionals Elects Leadership
http://pharmexec.findpharma.com/pharmexec/Discovery+NewsWire/Network-of-Cancer-Public-Affairs-and-Marketing-Pro/ArticleNewsFeed/Article/detail/522274?ref=25
2008-06-06T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlenewsfeed/pharmexec/232008/522274nullXMLUniversity of Colorado Cancer Center Leading New Clinical Trial Researching Latest Treatment for Recurrent
Prostate Cancer; Study Offers Hope to Prostate Patients Whose Cancer Returns Following Radiation
http://pharmexec.findpharma.com/pharmexec/Discovery+NewsWire/University-of-Colorado-Cancer-Center-Leading-New-C/ArticleNewsFeed/Article/detail/522020?ref=25
2008-06-05T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlenewsfeed/pharmexec/232008/522020nullXMLVisiting the South's 'Stroke Buckle' Increases Risk of Stroke Death
http://pharmexec.findpharma.com/pharmexec/Discovery+NewsWire/Visiting-the-Souths-Stroke-Buckle-Increases-Risk-o/ArticleNewsFeed/Article/detail/521984?ref=25
2008-06-05T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlenewsfeed/pharmexec/232008/521984nullXMLPrix Galien USA - The Galen Prize - Gala Awards Ceremony
http://pharmexec.findpharma.com/pharmexec/Prix-Galien-USA---The-Galen-Prize---Gala-Awards-Ce/ArticleStandard/Article/detail/521560?ref=25
Prix Galien USA - The Galen Prize - Gala Awards Ceremony2008-06-04T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/232008/521560nullHTMLPfizer's Full-Court Press to Save Chantix
http://pharmexec.findpharma.com/pharmexec/News/Pfizers-Full-Court-Press-to-Save-Chantix/ArticleStandard/Article/detail/521432?ref=25
Badly wounded by mounting fears of its safety profile and plunging prescriptions, Pfizer?s novel
smoking-cessation drug that promised blockbuster sales is now fighting for its life?with a no-holds-barred ad and
PR campaign.2008-06-04T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/232008/521432nullHTMLASCO's Take-Home and the Oncology Market
http://pharmexec.findpharma.com/pharmexec/News/ASCOs-Take-Home-and-the-Oncology-Market/ArticleStandard/Article/detail/521444?ref=25
With cancer pharma?s most competitive category, the big news from the annual oncology confab can big
changes in the market outlook. Two Decision Resources analyst round it up and break it down.2008-06-04T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/232008/521444nullHTMLSocial Networking Site for Cancer Docs: Bang or bust?
http://pharmexec.findpharma.com/pharmexec/News/Social-Networking-Site-for-Cancer-Docs-Bang-or-bus/ArticleStandard/Article/detail/521441?ref=25
MedTrust Online is pitching customized Web sites linking primary-care physicians to one another,
oncology specialists, and a trove of medical content has grabbed a lot of press. Can it fly?2008-06-04T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/232008/521441nullHTMLMore Girls Than Boys Benefit From Breast-Feeding, Hopkins Children's Research Shows; Gender Differences
Illuminate New Strategies for Future Therapy
http://pharmexec.findpharma.com/pharmexec/Discovery+NewsWire/More-Girls-Than-Boys-Benefit-From-Breast-Feeding-H/ArticleNewsFeed/Article/detail/520758?ref=25
2008-06-02T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlenewsfeed/pharmexec/232008/520758nullXMLLudwig Hantson, Novartis
http://pharmexec.findpharma.com/pharmexec/Ludwig-Hantson-Novartis/ArticleStandard/Article/detail/524379?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524379nullXMLSusanne Schaffert, Novartis
http://pharmexec.findpharma.com/pharmexec/Susanne-Schaffert-Novartis/ArticleStandard/Article/detail/524403?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524403nullXMLAdnan Mjalli, TransTech Pharma
http://pharmexec.findpharma.com/pharmexec/Adnan-Mjalli-TransTech-Pharma/ArticleStandard/Article/detail/524408?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524408nullXMLEvan Morris, Roche
http://pharmexec.findpharma.com/pharmexec/Evan-Morris-Roche/ArticleStandard/Article/detail/524418?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524418nullXMLDoctor's Orders
http://pharmexec.findpharma.com/pharmexec/Professional+Marketing/Doctors-Orders/ArticleStandard/Article/detail/523681?ref=25
Dr. Michael Kessler and Mark Vitello of MD Mindset have the cure for the common sales pitch? Look at
the transaction from the customer's perspective2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242008/523681nullXMLPerfectly Imperfect
http://pharmexec.findpharma.com/pharmexec/Leader/Perfectly-Imperfect/ArticleStandard/Article/detail/523686?ref=25
Everyone makes mistakes; how you handle them is the measure of a true leader2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242008/523686nullXMLBeing Bob: Q&A with Robert Essner
http://pharmexec.findpharma.com/pharmexec/Articles/Being-Bob-QampA-with-Robert-Essner/ArticleStandard/Article/detail/523689?ref=25
An industry legend weighs in on leadership, research, and sales models. Q&A with outgoing
Wyeth Chairman Bob Essner2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242008/523689nullXML45 Under 45:The Change Generation
http://pharmexec.findpharma.com/pharmexec/Rotating+Feature+Article/45-Under-45The-Change-Generation/ArticleStandard/Article/detail/524375?ref=25
In our first ever Emerging Leadership Awards, we profile 45 talented young professionals who will lead
pharma into the next generation2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524375/45under45_flash.jpgXMLMike Boken, Shire
http://pharmexec.findpharma.com/pharmexec/Mike-Boken-Shire/ArticleStandard/Article/detail/524382?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524382nullXML45 Under 45: The Judges
http://pharmexec.findpharma.com/pharmexec/45-Under-45-The-Judges/ArticleStandard/Article/detail/525005?ref=25
Judges for the 2008 45 Under 452008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/525005nullHTMLGreg Parekh, Novartis
http://pharmexec.findpharma.com/pharmexec/Greg-Parekh-Novartis/ArticleStandard/Article/detail/524390?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524390nullXMLJared Silverman, Cubist
http://pharmexec.findpharma.com/pharmexec/Jared-Silverman-Cubist/ArticleStandard/Article/detail/524395?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524395nullXMLDagmar Rosa-Bjorkeson, Novartis
http://pharmexec.findpharma.com/pharmexec/Dagmar-Rosa-Bjorkeson-Novartis/ArticleStandard/Article/detail/524399?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524399nullXMLDavid Newman, GlaxoSmithKline
http://pharmexec.findpharma.com/pharmexec/David-Newman-GlaxoSmithKline/ArticleStandard/Article/detail/524405?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524405nullXMLMichael Burke, Ovation
http://pharmexec.findpharma.com/pharmexec/Michael-Burke-Ovation/ArticleStandard/Article/detail/524409?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524409nullXMLJames Galeota, Merck
http://pharmexec.findpharma.com/pharmexec/James-Galeota-Merck/ArticleStandard/Article/detail/524412?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524412nullXMLCandidates Target Pharma
http://pharmexec.findpharma.com/pharmexec/Washington+Report/Candidates-Target-Pharma/ArticleStandard/Article/detail/523684?ref=25
US presidential hopefuls look to comparative effectiveness analysis to address price and access
issues2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242008/523684nullXMLTightening the Chain
http://pharmexec.findpharma.com/pharmexec/Global+Report/Tightening-the-Chain/ArticleStandard/Article/detail/523685?ref=25
EU makes plans to police its supply chain2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242008/523685nullXMLEric Floyd, Cephalon
http://pharmexec.findpharma.com/pharmexec/Eric-Floyd-Cephalon/ArticleStandard/Article/detail/524378?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524378nullXMLCameron Durrant, J&J
http://pharmexec.findpharma.com/pharmexec/Cameron-Durrant-JampJ/ArticleStandard/Article/detail/524381?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524381nullXMLJohn Shamsey, Bristol-Myers Squibb
http://pharmexec.findpharma.com/pharmexec/John-Shamsey-Bristol-Myers-Squibb/ArticleStandard/Article/detail/524392?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524392nullXMLChris Claiborne, Millennium
http://pharmexec.findpharma.com/pharmexec/Chris-Claiborne-Millennium/ArticleStandard/Article/detail/524394?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524394nullXMLMalvinder Singh, Ranbaxy Labs
http://pharmexec.findpharma.com/pharmexec/Malvinder-Singh-Ranbaxy-Labs/ArticleStandard/Article/detail/524400?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524400nullXMLJohn Orwin, Genentech
http://pharmexec.findpharma.com/pharmexec/John-Orwin-Genentech/ArticleStandard/Article/detail/524402?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524402nullXMLJeffrey Aronin, Ovation
http://pharmexec.findpharma.com/pharmexec/Jeffrey-Aronin-Ovation/ArticleStandard/Article/detail/524384?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524384nullXMLAndrin Oswald, Novartis
http://pharmexec.findpharma.com/pharmexec/Andrin-Oswald-Novartis/ArticleStandard/Article/detail/524386?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524386nullXMLBrett Villagrand, Genentech
http://pharmexec.findpharma.com/pharmexec/Brett-Villagrand-Genentech/ArticleStandard/Article/detail/524397?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524397nullXMLAmeet Mallik, Novartis
http://pharmexec.findpharma.com/pharmexec/Ameet-Mallik-Novartis/ArticleStandard/Article/detail/524411?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524411nullXMLBlueprint for Excellence
http://pharmexec.findpharma.com/pharmexec/Rotating+Feature+Article/Blueprint-for-Excellence/ArticleStandard/Article/detail/523690?ref=25
In a time of slow growth, true innovators forge new relationships with core customers2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242008/523690/blueprint_flash.jpgXMLThe Web Video (R)evolution
http://pharmexec.findpharma.com/pharmexec/E-Marketing/The-Web-Video-Revolution/ArticleStandard/Article/detail/523692?ref=25
Pharma is taking note of online video's power to affect B2B communications2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242008/523692nullXMLJulie McHugh, J&J
http://pharmexec.findpharma.com/pharmexec/Julie-McHugh-JampJ/ArticleStandard/Article/detail/524377?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524377nullXMLKurt Graves, Vertex
http://pharmexec.findpharma.com/pharmexec/Kurt-Graves-Vertex/ArticleStandard/Article/detail/524387?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524387nullXMLBarry Greene, Alnylam
http://pharmexec.findpharma.com/pharmexec/Barry-Greene-Alnylam/ArticleStandard/Article/detail/524393?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524393nullXMLRob Perez, EVP and COO, Cubist Pharmaceuticals
http://pharmexec.findpharma.com/pharmexec/Rob-Perez-EVP-and-COO-Cubist-Pharmaceuticals/ArticleStandard/Article/detail/524396?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524396nullXMLNancy Phelan, Wyeth
http://pharmexec.findpharma.com/pharmexec/Nancy-Phelan-Wyeth/ArticleStandard/Article/detail/524398?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524398nullXMLRich Tillyer, Merck
http://pharmexec.findpharma.com/pharmexec/Rich-Tillyer-Merck/ArticleStandard/Article/detail/524416?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524416nullXMLEverybody's Right
http://pharmexec.findpharma.com/pharmexec/From+the+Editor/Everybodys-Right/ArticleStandard/Article/detail/523682?ref=25
The great debate on DTC advertising is heating up again. We're going to be hearing a lot about fair
balance and risk communication and costs. But what about the patients?2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242008/523682nullXMLThe Buddy System
http://pharmexec.findpharma.com/pharmexec/Thought+Leader/The-Buddy-System/ArticleStandard/Article/detail/523683?ref=25
Jean-Marc Niemetz on forming partnerships with the industry's major stakeholders2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242008/523683nullXMLStealth Pharmas
http://pharmexec.findpharma.com/pharmexec/Rotating+Features+Article/Stealth-Pharmas/ArticleStandard/Article/detail/523688?ref=25
Second annual Not Big Pharma audit gives equal time to the little guys. Who's got the Midas
touch?2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242008/523688/stealthpharma_flash.jpgXMLAngela Moskow, Sanofi-Aventis
http://pharmexec.findpharma.com/pharmexec/Angela-Moskow-Sanofi-Aventis/ArticleStandard/Article/detail/524401?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524401nullXMLWendy Niebler, Shire
http://pharmexec.findpharma.com/pharmexec/Wendy-Niebler-Shire/ArticleStandard/Article/detail/524414?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524414nullXMLSean McLoughlin, GlaxoSmithKline
http://pharmexec.findpharma.com/pharmexec/Sean-McLoughlin-GlaxoSmithKline/ArticleStandard/Article/detail/524420?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524420nullXMLRelaunching Reform
http://pharmexec.findpharma.com/pharmexec/Opinion/Relaunching-Reform/ArticleStandard/Article/detail/523687?ref=25
This time, powerful interest groups (like pharma) that sank the Clinton healthcare bill are on the
side of change2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242008/523687nullXMLJ. Martin Jernigan, Novo Nordisk
http://pharmexec.findpharma.com/pharmexec/J-Martin-Jernigan-Novo-Nordisk/ArticleStandard/Article/detail/524388?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524388nullXMLVlad Hogenhuis, Merck
http://pharmexec.findpharma.com/pharmexec/Vlad-Hogenhuis-Merck/ArticleStandard/Article/detail/524406?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524406nullXMLErik Harris, Elan
http://pharmexec.findpharma.com/pharmexec/Erik-Harris-Elan/ArticleStandard/Article/detail/524415?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524415nullXMLTariq Arshad, Pfizer
http://pharmexec.findpharma.com/pharmexec/Tariq-Arshad-Pfizer/ArticleStandard/Article/detail/524417?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524417nullXMLMightier Than the Sword
http://pharmexec.findpharma.com/pharmexec/Direct+to+Consumer/Mightier-Than-the-Sword/ArticleStandard/Article/detail/523691?ref=25
When it comes to marketing, every syllable speaks volumes2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242008/523691nullXMLBlair Gibson, Merck
http://pharmexec.findpharma.com/pharmexec/Blair-Gibson-Merck/ArticleStandard/Article/detail/524380?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524380nullXMLAlan Tennenberg; Tibotec, J&J
http://pharmexec.findpharma.com/pharmexec/Alan-Tennenberg-Tibotec-JampJ/ArticleStandard/Article/detail/524383?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524383nullXMLKeeshia Muhammad, Teva Specialty Pharmaceuticals
http://pharmexec.findpharma.com/pharmexec/Keeshia-Muhammad-Teva-Specialty-Pharmaceuticals/ArticleStandard/Article/detail/524385?ref=25
Keeshia Muhammad2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524385nullXMLRoger Adsett, Shire
http://pharmexec.findpharma.com/pharmexec/Roger-Adsett-Shire/ArticleStandard/Article/detail/524404?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524404nullXMLMary Szela, Abbott
http://pharmexec.findpharma.com/pharmexec/Mary-Szela-Abbott/ArticleStandard/Article/detail/524407?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524407nullXMLMark Stejbach, Merck
http://pharmexec.findpharma.com/pharmexec/Mark-Stejbach-Merck/ArticleStandard/Article/detail/524410?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524410nullXMLSafi Bahcall, Synta Pharmaceuticals
http://pharmexec.findpharma.com/pharmexec/Safi-Bahcall-Synta-Pharmaceuticals/ArticleStandard/Article/detail/524413?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524413nullXMLKimberly Park, Internal Medicine for Janssen Ortho-McNeil Primary Care
http://pharmexec.findpharma.com/pharmexec/Kimberly-Park-Internal-Medicine-for-Janssen-Ortho-/ArticleStandard/Article/detail/524419?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524419nullXMLChristoph Westphal, Sirtris
http://pharmexec.findpharma.com/pharmexec/Christoph-Westphal-Sirtris/ArticleStandard/Article/detail/524376?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524376nullXMLSuzanne Delaney, AstraZeneca
http://pharmexec.findpharma.com/pharmexec/Suzanne-Delaney-AstraZeneca/ArticleStandard/Article/detail/524389?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524389nullXMLHoji Alimi, Oculus Innovative Sciences
http://pharmexec.findpharma.com/pharmexec/Hoji-Alimi-Oculus-Innovative-Sciences/ArticleStandard/Article/detail/524391?ref=25
S2008-06-01T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252008/524391nullXMLStudy Suggests Chemotherapy Diminishes Fertility in Breast Cancer Patients
http://pharmexec.findpharma.com/pharmexec/Discovery+NewsWire/Study-Suggests-Chemotherapy-Diminishes-Fertility-i/ArticleNewsFeed/Article/detail/519958?ref=25
2008-05-29T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlenewsfeed/pharmexec/222008/519958nullXMLStudents' Device Allows ICU Patients to Get Back on Their Feet; Researchers Believe Walking Could Help
Critically Ill People Recover More Quickly
http://pharmexec.findpharma.com/pharmexec/Students-Device-Allows-ICU-Patients-to-Get-Back-on/ArticleNewsFeed/Article/detail/519956?ref=25
2008-05-29T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlenewsfeed/pharmexec/222008/519956nullXMLBlack Patients With Terminal Cancer More Likely to Choose Aggressive Care at End of Life, Study
Shows
http://pharmexec.findpharma.com/pharmexec/Discovery+NewsWire/Black-Patients-With-Terminal-Cancer-More-Likely-to/ArticleNewsFeed/Article/detail/519963?ref=25
2008-05-29T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlenewsfeed/pharmexec/222008/519963nullXMLCentral Registries Hold Annual Cancer Surveillance Meeting
http://pharmexec.findpharma.com/pharmexec/Discovery+NewsWire/Central-Registries-Hold-Annual-Cancer-Surveillance/ArticleNewsFeed/Article/detail/519962?ref=25
2008-05-29T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlenewsfeed/pharmexec/222008/519962nullXMLBook Details Provocative, Sometimes Gruesome History of Organ, Blood Donations
http://pharmexec.findpharma.com/pharmexec/Book-Details-Provocative-Sometimes-Gruesome-Histor/ArticleNewsFeed/Article/detail/519960?ref=25
2008-05-29T04:00:00Z
http://pharmexec.findpharma.com/pharmexec/data/articlenewsfeed/pharmexec/222008/519960nullXML